OUTLOOK THERAPEUTICS INC. news, videos and press releases
For more news please use our advanced search feature.
OUTLOOK THERAPEUTICS INC. - More news...
OUTLOOK THERAPEUTICS INC. - More news...
- Outlook Therapeutics Completes Patient Enrollment for NORSE 1 a Phase 3 Clinical Trial for ONS-5010 in Wet AMD
- Outlook Therapeutics Provides Business Update and Reports Financial Results for Third Quarter of Fiscal 2019
- Outlook Therapeutics Doses First Patient in the Second Phase 3 Clinical Trial for ONS-5010 in Wet AMD
- Outlook Therapeutics Signs Manufacturing Supply Agreement with FUJIFILM Diosynth Biotechnologies as Part of Commercialization Strategy for ONS-5010
- Outlook Therapeutics Provides Business Update and Reports Second Quarter Financial Results for Fiscal 2019
- Outlook Therapeutics Announces Addition of Jennifer M. Kissner, Ph.D. as Senior Vice President, Clinical Development
- Outlook Therapeutics Announces Pricing of Public Offering of Common Stock and Warrants
- Outlook Therapeutics Announces FDA Acceptance of IND for ONS-5010
- Outlook Therapeutics Announces Reverse Stock Split
- Outlook Therapeutics Regains Compliance With All Nasdaq Listing Requirements
- Outlook Therapeutics Submits IND Application for ONS-5010 to the FDA
- Outlook Therapeutics Provides Business Update and Reports First Quarter Financial Results for Fiscal 2019
- Outlook Therapeutics Closes Final Tranche of $20 Million Private Placement
- Outlook Therapeutics Announces Exercise Price Reduction and Term Extension of Series A Warrants